# Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

> **NCT05924620** · PHASE4 · COMPLETED · sponsor: **Chongqing Medical University** · enrollment: 60 (actual)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **DRUG:** finerenone

## Key facts

- **NCT ID:** NCT05924620
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-21
- **Primary completion:** 2024-03-12
- **Final completion:** 2024-03-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05924620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05924620, "Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05924620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*